Hybrid Cochlear Implants in Severe to Profound Adults, Children, and Adolescents
Hearing Loss, High-Frequency
Bottom Line
View on ClinicalTrials.gov: NCT01975571 ↗Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Cochlear® Nucleus™ Hybrid L24 (Device); Cochlear® Nucleus™ Hybrid S12 (Device)
- Age
- Pediatric, Adult, Older Adult · 5+ yrs
- Sex
- All
- Sponsor
- Bruce J Gantz
- Primary completion
- Sep 2018
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change in CNC Word Perception |
27.6; 34; 55.9; 68; 63.5; 64 | — |
| SECONDARY Change in Localization |
23; 18; 34; 26; 32; 24 | — |
| SECONDARY AzBio +5 Noise |
14.6; 26.4; 36.3; 46.5; 51.4 | — |
Summary
Eligibility Criteria
Inclusion Criteria
1.1 Criteria for Inclusion in Population 1
Criterion for selection will be subject interest in preservation of residual hearing; severe sensorineural hearing loss; lack of benefit from appropriately fit binaural hearing aids worn on a full-time basis; and realistic expectations. Qualified participants must also meet the following criteria for inclusion:
- Eighteen year of age or older at the time of implantation.
- Severe sensorineural hearing loss with a pure-tone average (PTA) between 60-90 dB HL between 125-1500 Hz and profound loss at higher frequencies in the ear to be implanted.
- Speech Perception:
- The Consonant-Nucleus-Consonant (CNC) word recognition score between 0% and 35% inclusive in the ear to be implanted.
- The CNC word recognition score in the contralateral ear equal to or better than, in the ear to be implanted but not more than 60% in the best-aided condition.
- English spoken as a primary language.
- Willingness to comply with all study requirements.
- Minimum of 30 day hearing aid trial with appropriately fit hearing aids worn on a full-time basis (8 hours per day).
- Patent cochlea and normal cochlear anatomy.
1.2 Criteria for Inclusion in Population 2
Criterion for selection will be parent interest in preservation of residual hearing; severe post-lingual onset of sensorineural hearing loss; lack of benefit from appropriately fit binaural hearing aids worn on a full-time basis; and supportive family dynamics. Qualified participants must also meet the following criteria for inclusion:
- Five to fifteen years of age at the time of implantation.
- Severe sensorineural hearing loss with a pure-tone average (PTA) between 60-90 dB HL between 125-1500 Hz and profound loss at higher frequencies in the ear to be implanted.
- Speech Perception:
- The Phonetically Balanced-Kindergarten (PB-K) word recognition score between 0% and 50% inclusive in the ear to be implanted.
- The PB-K word recognition score in the contralateral ear equal to or better than, in the ear to be implanted but not more than 60%.
- English spoken as a primary language.
- Willingness to comply with all study requirements.
- Minimum of 30-day hearing aid trial with appropriately fit hearing aids worn on a full-time basis (8 hours per day)..
- Patent cochlea and normal cochlear anatomy.
- Must be in a habilitation/educational program with an emphasis on spoken language development.
Exclusion Criteria
1.3 Criteria for Exclusion in Populations 1 and 2
- Medical or psychological conditions that contraindicate undergoing surgery.
- Ossification or any other cochlear anomaly that might prevent complete insertion of the electrode array.
- Unrealistic expectations on the part of the candidate and/or candidate's family, regarding the possible benefits, risks, and limitations that are inherent to the surgical procedure(s) and prosthetic devices.
- Unwillingness or inability of the candidate to comply with all investigational requirements.
- Active middle ear infection.
Data sourced from ClinicalTrials.gov (NCT01975571). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.